Professional Documents
Culture Documents
19.neonatal Jaundice
19.neonatal Jaundice
07/23/11
Objectives
Review normal bilirubin metabolism and describe how it varies in the neonatal period. Describe the different types and causes of neonatal jaundice including physiologic jaundice, breast milk jaundice, breast feeding jaundice, and pathologic jaundice Discuss treatment options for hyperbilirubinemia including phototherapy, exchange transfusion, and experimental treatments.
07/23/11
Definition
07/23/11
Deposition of unconjugated (indirect) bilirubin onto the skin & mucus membranes Caused by increased bilirubin levels
Head to toe progression
Face > 5 mg/dL Upper Chest > 10 mg/dL Abdomen > 12 mg/dL Palms/Soles >15 mg/dL
Neonatal Hyperbilirubinemia
Total Bilirubin (indirect+direct) level > 5 mg/dL
3
75% from catabolism of circulating RBC 25% from ineffective erythropoesis and turnover of heme protein and free heme
Bonemarrow
RETICULOEND OTHELIAL SYSTEM (RES)
Hgb hem e oxygena se Biliverdin Biliverdin re ductase Bilirubin Fe Globin
Hgb Globin + He me Fe +
RBCs
Kid y ne
Bilirubin-Albumin Co mple x
ENTEROHEPATIC CIRC
Urine urobilinoge n
excretion Hydrolysis Bilirubin
In tin tes e
Urobilinogen Stercobilin
07/23/11
Bilirubin Forms
Unconjugated bilirubin
Does not cross blood-brain-barier (BBB) Distruption of this bond by certain drugs (sulfa drugs, ceftriaxone, free fatty acids), hypothermia, hypoxia, acidosis
07/23/11
Bound to albumin
Conjugated bilirubin
Bilirubin glucuronide
Physiologic Jaundice
Clinical jaundice develops in 50%-65% of all newborns
07/23/11
Jaundice appears after 24 hrs of age Total bilirubin rises by less than 5 mg/dl (86 mmol/l) per day
Contributing factors
UDPGT inactivity at birth Relatively high RBC mass Absence of intestinal flora Slow intestinal motility leading to an active enterohepatic circulation
Physiologic Jaundice
Full term infants
Peak bilirubin occurs at age 3 to 5 days with total bilirubin of no more than 15 mg/dl (258 mmol/l) Only 3% develop serum bilirubin levels > 15 mg/dl Jaundice is resolved by 1 week
07/23/11
Premature infants
Higher bilirubin levels with later peak (6-7 days) Jaundice is resolved by 2 weeks of age
10
12
Jaundice should be considered a possible sign of failure to establish an adequate milk supply and should prompt specific inquires into this possibilty
Weight loss >10% from birth Fewer than 6 wet diapers by day 3-4 Fewer than 4 stools per day Nursing fewer than 8 times per 24 hrs for at least 10 min each feed
If intake is inadequate, the infant should receive supplementation with formula, and mother should be instructed to nurse more frequently
13
14
15
Pathological Jaundice
Characteristics
Onest is usually within the first 24 hrs of life. Rate of increase > 0.5 mg/dl/hr (8.6 mmol/l/hr) Evidence of underlying illness
Gastrointestinal Hematologic Infectious
07/23/11
Jaundice that persists greater than 8 days in term infants and 14 days in preterm infants
16
17
18
Gilbert syndrome
Mild autosomal dominant disorder Decreased hepatic UDPGT levels
19
Biliary atresia
20
Bilirubin Toxicity
07/23/11
21
22
07/23/11
Bilirubin Toxicity
Three phases
07/23/11
Jaundice, hypotonia, lethargy, poor feeding, poor suck After few days: hypertonia, high-pitched cry, fever, seizures After about one week: hypertonia replaced by hypotonia, long-term neuronal injury
23
Bilirubin Toxicity
Extrapyramidal disturbances (choreoathetosis) Hearing loss Limitation of upward gaze Dental dysplasia Mild intellectual deficits
07/23/11
24
Diagnosis History
Family hx
Previous sibling with jaundice in the neonatal period, particularly if the jaundice required treatment ABO or Rh incompartibility, hereditary sphirocytosis etc Other family members with jaundice or known family history of Gilbert syndrome Anemia, splenectomy, or bile stones in family members or known heredity for hemolytic disorders Liver disease
07/23/11
25
26
Postnatal history
Loss of stool color Breastfeeding Greater than average weight loss Symptoms or signs of hypothyroidism Symptoms or signs of metabolic disease (eg, galactosemia) Exposure to total parental nutrition
07/23/11
27
Physical Examination
Jaundice is visible when bilirubin > 7 mg/dl (120 mmol/l)
In adults >2 mg/dl (35 mmol/l)
07/23/11
Visual inspection does not demonstrate good predictive ability Cephalocaudal progression
28
Physical Exam
Evaluate
Prematurity/SGA Extravascular blood
Cephalohematoma or other bruising
07/23/11
Pallor
Hemolysis; extravascular blood
Petechiae
Congenital infections; sepsis
HSM
Congenital infection; liver disease
29
1
Indire Se ct rum Bilirubin Conce ntratio n and It Re io To The Prog ss s lat n re ion of De rmal Icte in Full-Te Infants rus rm *
07/23/11
2
Bilirubin (m /1 m g 00 L) De al rm Zo ne Me n SD a 5 0 .9 .3 8 1 .9 .7 1 1.8 1.8 1 1 5 .7 Ra e ng 4 7 .3 .9 5 1 .4 2.2 8 1 .1 6.5 1 18 7 1.1 .3 >5 1 Obs rv tio e a ns 1 3 4 9 5 2 4 5 2 9
1 2 3 4 5
4
*Inc esall in tswh e rate of s lud fan os erum b ilirub ris was0.7 in e mg L /h or les . /d s
5 De a Zone o J a rm l s f undice
30
Studies
Bilirubin level Infants blood type and direct Coombs test Mothers blood type and antibody screening Peripheral smear for RBC morphology Hematocrit level (polycythemia or anemia) Reticulocyte count Others depending on course
LFTs, sepsis evaluation
31
07/23/11
Management
Management of jaundice is directed towards: - reducing the level of bilirubin and - preventing CNS toxicity. 1.Prevention of hyperbilirubinemia i.Early and frequent feeding ii.Adequate hydration 2.Reduction of bilirubin:This is achieved by - phototherapy or/and - exchange transfusion.
07/23/11
32
Management cont
Phototherapy
07/23/11
This involves exposure of the naked baby to blue,cool white or green light ofwave length 425-475 nm. The light waves convert the bilirubin to water soluble nontoxic forms which are then easily excreted. Every attempt should be made to find out the cause of jaundice. The advantages of phototherapy are that it is noninvasive,effective,inexpensive and easy to use.
33
Management
Clinical assessment of bilirubin level should not be relied upon in an infant under phototherapy. Frequent feeding every 2 hrly and change of posture should be promoted in an infant receiving phototherapy. Eye shades should be fixed. External genitalia may be covered as long as the infant is receiving phototherapy. Additional oral intake of plain water or glucose water is neither recommended nor necessary.
07/23/11
34
Baby is turned every two hours or after each feed. Temperature is monitored every two to four hours. Weight is taken at least once a day. More frequent breastfeeding or 10-20%extra fluid is provided. .Urine frequency is monitored daily. Serum bilirubin is monitored at least every 12 hours. Phototherapy is discontinued if two serum bilirubin values are <10 mg/dl.
35
07/23/11
Side effects of phototherapy - Increased insensible water loss:Provide more frequent and for longer duration extra breast feeding. - Loose green stools:weigh often and compensate with breast milk. - Skin rashes:Harmless,no need to discontinue phototherapy; - Bronze baby syndrome:occurs if baby has conjugated hyperbilirubinemia.If so,discontinue phototherapy; - Hypo or hyperthermia:monitor temperature frequently.
36
07/23/11
Management
Exchange transfusion
Exchange transfusion (approximately 160-200 ml/kg body weight) remains necessary in some cases of hemolysis resulting from Rh isoimmunization, ABO incompatibility, or hereditary spherocytosis Used when bilirubin level is more than 25g/dl total bilirubin In addition to decreasing the bilirubin level by approximately 50% acutely, the exchange transfusion also removes nearly 80% of the sensitized or abnormal RBC and offending antibodies so that ongoing hemolysis will be deceased
07/23/11
37
Management
Exchange transfusion
07/23/11
Procedure is invasive and not without risk The risk of mortality is 1-5%
Risk is greatest in the smallest, most immature, and otherwise unstable infants, but sudden death during the procedure can occur in any infant
Risk of serious complications such as NEC, infection, electolyte disturbances, or thrombocytopenia is 510%
38
Management
Exchange transfusion
07/23/11
39
Management
Experimental pharmacotherapy
Phenobarbital
Increases uptake Increases bile flow
07/23/11
40
Summary
Bilirubin is a normal product of heme metabolism. In newborns, various factors lead to increased levels of bilirubin due to either increased production of bilirubin or decreased elimination of bilirubin. Maternal history and careful examination of the infant are important in diagnosing the cause of pathologic jaundice. Phototherapy is the hallmark of treatment of unconjugated hyperbilirubinemia with exchange transfusion being reserved for the most severe or refractory cases.
07/23/11
41
THANK YOU !
07/23/11
42